In bone biology, specific PI-PLC isoforms modulate osteoblast differentiation, osteoclast activity, and extracellular vesicle-mediated signaling, with dysregulation implicated in diseases such as osteosarcoma and metabolic bone disorders. Here, PLCB1 is linked to osteosarcoma.